Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 21, 2026 13:30 ET | Source: Custom Market Insights

[Latest] Global Genome Editing Market Size/Share Worth USD 55.7 Billion by 2035 at a 17.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, May 21, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Genome Editing Market Size, Trends and Insights By Technology (CRISPR)/Cas9,...
May 21, 2026 09:35 ET | Source: Cordell and Cordell

National Law Firm Study Shows Major Shifts in Legal Space Driven by AI, Social Media, and Cryptocurrency

St. Louis, Mo., May 21, 2026 (GLOBE NEWSWIRE) -- ST. LOUIS, Mo. (May 21, 2026) — Cordell & Cordell’s new report, "Five Ways AI, Social Media, and Crypto are Dramatically Changing Family Law,"...
May 21, 2026 08:00 ET | Source: NordStellar

NordStellar research reveals ransomware's manipulative sales pitch: Threats, discounts, and "security audits"

NordStellar: Q1 2026 ransomware attacks stay high; leaked negotiation analysis shows attackers use sales tactics like multiple pricing tiers and discounts.
May 21, 2026 03:30 ET | Source: Orion Oyj

Orion Pharma to present its first clinical data from Phase 1/2 TEADES trial of TEAD inhibitor ODM-212 at the 2026 ASCO® Annual Meeting

ORION CORPORATION PRESS RELEASE 21 MAY 2026 at 10:30 EEST Orion Pharma to present its first clinical data from Phase 1/2 TEADES trial of TEAD inhibitor ODM-212 at the 2026 ASCO® Annual Meeting First...
May 21, 2026 03:30 ET | Source: Orion Oyj

Orion Pharma julkistaa ensimmäisiä kliinisiä tuloksia Faasi 1/2 TEADES-tutkimuksesta ODM-212-molekyylillä (TEAD-estäjä) 2026 ASCO®-vuosikokouksessa

ORION OYJ LEHDISTÖTIEDOTE 21.5.2026 KLO 10.30 Orion Pharma julkistaa ensimmäisiä kliinisiä tuloksia Faasi 1/2 TEADES-tutkimuksesta ODM-212-molekyylillä (TEAD-estäjä) 2026...
May 18, 2026 08:30 ET | Source: Medidata Solutions, Inc.

Medidata’s Second Annual AI Report Shows a Shift from Pilots to Enterprise Adoption with 72.9% of Early Adopters Seeing a Reduction in Study Timelines

NEW YORK, May 18, 2026 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today released its second annual report...
May 14, 2026 07:30 ET | Source: MiNK Therapeutics

MiNK Therapeutics and First Lviv Territorial Medical Union Initiate Randomized Phase 2 Trial of agenT-797 in Acute Lung Injury and Critical Illness

Randomized Phase 2 trial evaluates off-the-shelf invariant natural killer T (iNKT) cell therapy in patients with acute lung injury and hypoxemic respiratory failure Study initiates in Lviv, Ukraine,...
May 13, 2026 09:05 ET | Source: Spur Intelligence

Spur IP Intelligence Study: Nearly Every Modern Cyberattack Now Leveraging Anonymizing Infrastructure and Victims are Blind to it

LAKE MARY, Fla., May 13, 2026 (GLOBE NEWSWIRE) -- Spur Intelligence released findings from its 2026 IP Intelligence Study, revealing that anonymizing infrastructure, such as VPNs and residential...
May 11, 2026 05:00 ET | Source: BASF Agricultural Solutions

BASF Agricultural Solutions successfully commissions new fermentation plant for crop protection products in Ludwigshafen

BASF commissions new BioHub fermentation plant in Ludwigshafen, expanding biological crop protection and strengthening flexible, resilient supply chains.
May 07, 2026 12:00 ET | Source: Edmentum

Edmentum Research Confirms Causal Impact of Virtual Tutoring on Student Achievement

Bloomington, Minn., May 07, 2026 (GLOBE NEWSWIRE) -- Edmentum, the leading provider of K-12 digital curriculum, assessments, and learning interventions, has released new efficacy research...